A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation

  1. Robert B. Darnell1,2,6
  1. 1Laboratory of Molecular Neuro-Oncology, The Rockefeller University, New York, New York 10065, USA;
  2. 2Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10065, USA;
  3. 3Department of Microbiology, Division of Diagnostics and Intervention, Institute of Clinical Medicine, Oslo University Hospital, Rikshospitalet, NO-0027, Oslo, Norway;
  4. 4Department of Molecular Medicine, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, 0316 Oslo, Norway;
  5. 5Laboratory of Molecular Cell Biology, The Rockefeller University, New York, New York 10065, USA;
  6. 6New York Genome Center, New York, New York 10013, USA;
  7. 7Proteomics and Metabolomics Core Facility, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7489 Trondheim, Norway
  1. Corresponding authors: darnelr{at}rockefeller.edu, darnell{at}rockefeller.edu
  1. 8 These authors contributed equally to this work.

  • 9 Present address: Department of Physiology, University of Cambridge, Cambridge CB2 3DY, UK.

Abstract

We adapted UV CLIP (cross-linking immunoprecipitation) to accurately locate tens of thousands of m6A residues in mammalian mRNA with single-nucleotide resolution. More than 70% of these residues are present in the 3′-most (last) exons, with a very sharp rise (sixfold) within 150–400 nucleotides of the start of the last exon. Two-thirds of last exon m6A and >40% of all m6A in mRNA are present in 3′ untranslated regions (UTRs); contrary to earlier suggestions, there is no preference for location of m6A sites around stop codons. Moreover, m6A is significantly higher in noncoding last exons than in next-to-last exons harboring stop codons. We found that m6A density peaks early in the 3′ UTR and that, among transcripts with alternative polyA (APA) usage in both the brain and the liver, brain transcripts preferentially use distal polyA sites, as reported, and also show higher proximal m6A density in the last exons. Furthermore, when we reduced m6A methylation by knocking down components of the methylase complex and then examined 661 transcripts with proximal m6A peaks in last exons, we identified a set of 111 transcripts with altered (approximately two-thirds increased proximal) APA use. Taken together, these observations suggest a role of m6A modification in regulating proximal alternative polyA choice.

Keywords

Footnotes

  • Received July 28, 2015.
  • Accepted September 1, 2015.

This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.

| Table of Contents

Life Science Alliance